A bioinformatics company offers affordable genetic clinical tests for planned pregnancies.

Parents are always worried about the well-being of their children, and the fear of passing on hereditary diseases to offspring has some expecting couples reaching out to doctors ever-so-willingly. Having raised $3.3 million in venture funds, New Jersey-based biotech startup Recombine is offering affordable genetic tests that could help parents better plan for health-related issues that may affect their children.

The company’s test, called CarrierMap, analyzes blood and saliva samples for 213 genetic disorders at once, and only costs $345, a slash in price when compared to services offered by other clinical genetic testing services. Recombine genetic counselors are there to explain test results, which can be obtained one to two weeks after testing.

This content is available for Basic Members.
Already a member, log in